logo

For the Inventor, By the Inventor

Chanhassen, MN, United States of America

Jody Bonnevier

This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignee: Bio-Techne Corporation. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jody Bonnevier. Retrieved from https://idiyas.com/inventor/jody-bonnevier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:

goldMedal4 out of 12 
 
Bio-Techne Corporation
 patents

Years Active: 2020-2026

Loading Chart...
4 patents (USPTO):Explore Patents
1. 12704517 - ANTI-SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS ANTIBODIES (2026-08-11),
2. 11897958 - Hybridoma clones, monoclonal antibodies to VSIG-4, and methods of making and using (2024-02-13),
3. 11787857 - Compounds that modulate the interaction of VISTA and VSIG3 and methods of making and using (2023-10-17),
4. 10752689 - Hybridoma clones, monoclonal antibodies to VSIG-4, and methods of making and using (2020-08-25),

Title: The Innovative Journey of Jody Bonnevier

Introduction

Jody Bonnevier, an accomplished inventor based in Chanhassen, Minnesota, has made significant contributions to the field of biotechnology. With a total of three patents to his name, Bonnevier is renowned for his work involving monoclonal antibodies, which play a vital role in medical research and treatment.

Latest Patents

Jody's latest patents reflect his groundbreaking work in immunology. One of his patents focuses on hybridoma clones and monoclonal antibodies that bind to VSIG-4, detailing methods for creating and utilizing these antibodies. This includes innovative compositions that block the interaction of VSIG-4 with SIGLEC-7. Another patent centers on compounds that modulate the relationship between VISTA and VSIG-3, along with methods for producing and using polyclonal and monoclonal antibodies that interact with VSIG-3. These contributions demonstrate Bonnevier's commitment to advancing therapeutic options in immunology.

Career Highlights

Throughout his career, Jody Bonnevier has been associated with Bio-Techne Corporation, a respected name in the biotechnology industry. His work at the company has allowed him to advance his research and development efforts significantly. Jody's inventions not only contribute to scientific understanding but also pave the way for advancements in clinical applications.

Collaborations

Collaboration is key to innovation, and Jody is fortunate to work alongside talented colleagues such as Birte Aggeler and Christine Goetz. Together, they share knowledge and expertise, propelling their collective research forward. These partnerships enhance the creative process and foster a productive environment for scientific breakthroughs.

Conclusion

Jody Bonnevier stands out as a remarkable inventor whose work has far-reaching implications in biotechnology. With his patented innovations, he is working towards improving medical interventions and enhancing our understanding of immune responses. As he continues his journey in research and development at Bio-Techne Corporation, the scientific community eagerly anticipates his future contributions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…